Strattera and Viibryd drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Strattera (atomoxetine hydrochloride) and Viibryd (vilazodone hydrochloride). Common drug interactions include adverse event among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Strattera and Viibryd. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,323 Strattera users. Check the latest studies of Strattera.

What is Viibryd?

Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. eHealthMe is studying from 11,106 Viibryd users. Check the latest studies of Viibryd.

On Jul, 14, 2026

39 people who take Strattera and Viibryd together, and have interactions are studied.

Strattera and Viibryd drug interactions.

What are the common drug interactions of Strattera and Viibryd, by gender? *:

female:

Adverse event
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
Thyroid disorder (thyroid diseases)
Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
Fibromyalgia (a long-term condition which causes pain all over the body)
Ovarian cyst (fluid filled sac of the ovary)
Sinusitis (inflammation of sinus)
Aggression
Anger
Impaired driving ability

male:

Dizziness
Drug ineffective
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Photophobia (extreme sensitivity to light)
Suicidal ideation
Vision blurred
Affective disorder (mental disorder)
Akathisia (a movement disorder characterized by a feeling of inner restlessness)
Asthenia (weakness)
Blood testosterone decreased

What are the common drug interactions of Strattera and Viibryd, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Haemoglobin decreased
Menometrorrhagia (a condition in which prolonged or excessive uterine bleeding occurs irregularly and more frequently than normal)
Menstruation irregular

20-29:

Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
Ovarian cyst (fluid filled sac of the ovary)
Dry eye (lack of adequate tears)
Photophobia (extreme sensitivity to light)
Suicidal ideation
Vision blurred

30-39:

Drug ineffective
Head injury
Headache (pain in head)
Hepatic enzyme increased
Herpes zoster
Hypertension (high blood pressure)
Loss of consciousness
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Muscle spasms (muscle contraction)

40-49:

Osteoporosis (bones weak and more likely to break)
Therapeutic response unexpected
Chronic kidney disease
General symptom
Influenza like illness
Memory impairment
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Speech disorder

50-59:

Adverse event
Blood pressure decreased
Blood testosterone decreased
Constipation
Dehydration (dryness resulting from the removal of water)
Drug ineffective
Dry skin
Headache (pain in head)
Heart rate increased
Hyperhidrosis (abnormally increased sweating)

60+:

Rash maculo-papular (red area on the skin that is covered with small confluent bumps)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 13 people, 33.33%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 13 people, 33.33%
Drowsiness: 4 people, 10.26%
Stress And Anxiety: 3 people, 7.69%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 7.69%
Insomnia (sleeplessness): 2 people, 5.13%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 2 people, 5.13%
Herpes Zoster: 2 people, 5.13%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 5.13%
Blood Testosterone Decreased: 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and Viibryd?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously